Carnegie Capital Asset Management, LLC Amgen Inc Transaction History
Carnegie Capital Asset Management, LLC
- $3.38 Billion
- Q4 2024
A detailed history of Carnegie Capital Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 104,819 shares of AMGN stock, worth $28.7 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
104,819
Previous 99,420
5.43%
Holding current value
$28.7 Million
Previous $32 Million
14.72%
% of portfolio
0.81%
Previous 0.96%
Shares
32 transactions
Others Institutions Holding AMGN
# of Institutions
3,084Shares Held
405MCall Options Held
7.56MPut Options Held
7.16M-
Vanguard Group Inc Valley Forge, PA52.4MShares$14.3 Billion0.31% of portfolio
-
Black Rock Inc. New York, NY46MShares$12.6 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.3MShares$8.02 Billion0.39% of portfolio
-
Morgan Stanley New York, NY14.7MShares$4.02 Billion0.35% of portfolio
-
Primecap Management CO Pasadena, CA14.3MShares$3.9 Billion3.44% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $146B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...